Drug intelligence / Profile preview

Shufeiya prescription

Development stage
Unknown
Lead developer
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Administration
Oral
01

Overview

**Shufeiya prescription** is an investigational traditional Chinese herbal formula comprising *Salvia miltiorrhiza* root and rhizome, safflower flower, *Cornus officinalis* fruit, and *Platycodon grandiflorus* root. It is being studied for pulmonary hypertension. In monocrotaline-induced pulmonary-hypertension rat models, the formula reduced mean pulmonary artery pressure and was associated with modulation of oxidative-stress and nitric-oxide signaling, including SIRT3/FOXO3a, PI3K/AKT/eNOS, NO-sGC-cGMP-PKG, and Ras/MEK/ERK pathways. A registered early-phase clinical study evaluates effects on pulmonary artery systolic pressure and quality of life in patients with pulmonary hypertension. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC8881168/))

Other names
SFYShufeiyaShufeiya Recipe
02

Targets

IL-6 (Interleukin 6)EGFR T790M (Epidermal growth factor receptor T790M mutant)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)MAPK3 (Mitogen-activated protein kinase 1)NOS3 (eNOS)

Beyond the preview

Go deeper on Shufeiya prescription.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shufeiya prescription.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call